Tobacco Products Scientific Advisory Committee

The Mark Foundation Announces 2023 Endeavor Awards; $12 Million in Grants for Collaborative Cancer Research Projects

Retrieved on: 
Tuesday, October 17, 2023

NEW YORK, Oct. 17, 2023 /PRNewswire/ -- The Mark Foundation for Cancer Research announced the recipients of its 2023 Endeavor Award program, providing a total of $12M across seven institutions to support teams of scientists tackling a range of urgent challenges in the prevention, diagnosis, and treatment of cancer. These $3 million grants are awarded over a three-year term to accelerate progress in high-priority research areas through a collaborative approach.

Key Points: 
  • These $3 million grants are awarded over a three-year term to accelerate progress in high-priority research areas through a collaborative approach.
  • The finalists participated in a rigorous selection process, including live interviews conducted by The Mark Foundation's Scientific Advisory Committee, chaired by Ross Levine, MD, of Memorial Sloan Kettering Cancer Center.
  • "These four teams of scientists are poised to take on some major questions in cancer research," said Dr. Levine.
  • For more detailed information, project titles link to the corresponding project summary on The Mark Foundation website.

Kamada Announces Recent Achievements with CYTOGAM® including Availability of Product Manufactured by the Company for U.S Commercial Sale and Presentation of New Clinical Data

Retrieved on: 
Monday, October 16, 2023

Kamada announced that CYTOGAM manufactured at the Company’s facility in Beit Kama, Israel, is now available for commercial sales in the U.S.

Key Points: 
  • Kamada announced that CYTOGAM manufactured at the Company’s facility in Beit Kama, Israel, is now available for commercial sales in the U.S.
  • This follows the recent FDA approval of the technology transfer process of CYTOGAM from its previous manufacturer, CSL Behring.
  • The availability of Kamada-manufactured CYTOGAM in Canada is expected later this year.
  • The advisory board focuses on Kamada’s newly implemented U.S. clinical program for CYTOGAM including new opportunities and future research and development possibilities.

Global Humane Launches Humane Tourism Certification Program

Retrieved on: 
Thursday, October 5, 2023

WASHINGTON, Oct. 05, 2023 (GLOBE NEWSWIRE) -- Global Humane has extended its conservation impact with a new Humane Tourism™ program.

Key Points: 
  • WASHINGTON, Oct. 05, 2023 (GLOBE NEWSWIRE) -- Global Humane has extended its conservation impact with a new Humane Tourism™ program.
  • As millions of people worldwide seek opportunities to connect with Earth’s majestic wildlife, Global Humane has identified an opportunity to apply our expertise in animal welfare and create a unique certification program in humane tourism.
  • Mantis, a leading conservation-focused hotel brand within the Accor group has attained the first Global Humane Certified™ designation for Humane Tourism™ at four select locations.
  • “We are thrilled that Mantis has met the standards to attain the first Global Humane Tourism certification,” said Dr. Robin Ganzert, President and CEO Global Humane.

Global Humane Launches Humane Tourism™ Certification Program

Retrieved on: 
Thursday, October 5, 2023

WASHINGTON, Oct. 5, 2023 /PRNewswire/ -- Global Humane has extended its conservation impact with a new Humane Tourism™ program. As millions of people worldwide seek opportunities to connect with Earth's majestic wildlife, Global Humane has identified an opportunity to apply our expertise in animal welfare and create a unique certification program in humane tourism.

Key Points: 
  • Mantis, a leading hotel eco-brand within the Accor Group, is the first to receive the prestigious designation
    WASHINGTON, Oct. 5, 2023 /PRNewswire/ -- Global Humane has extended its conservation impact with a new Humane Tourism™ program.
  • As millions of people worldwide seek opportunities to connect with Earth's majestic wildlife, Global Humane has identified an opportunity to apply our expertise in animal welfare and create a unique certification program in humane tourism.
  • Mantis, a leading conservation-focused hotel brand within the Accor group has attained the first Global Humane Certified™ designation for Humane Tourism™ at four select locations.
  • "We are thrilled that Mantis has met the standards to attain the first Global Humane Tourism certification," said Dr. Robin Ganzert, President and CEO Global Humane.

Whole Foods Market Celebrates 20 Years as a Certified Organic Grocer

Retrieved on: 
Monday, September 18, 2023

This year marks 20 years since Whole Foods Market first attained organic retail certification.

Key Points: 
  • This year marks 20 years since Whole Foods Market first attained organic retail certification.
  • “Whole Foods Market is proud to celebrate 20 years as the only certified organic national grocer in the industry and continue our work to help grow and support the organic community,” said Jason Buechel, chief executive officer at Whole Foods Market.
  • “Our Team Members work hard to ensure the organic integrity of our products all the way from the farm to customer selection from our shelves.”
    Whole Foods Market has championed organic since before there was a National Organic Program and requires certification for organic label claims on all products it sells.
  • Whole Foods Market continues to advocate for legislation supporting the adoption of organic and other climate-smart agricultural practices, while reducing infrastructural challenges and barriers to the market.

ARS Reports Second Quarter 2023 Financial Results and Provides Business Updates

Retrieved on: 
Thursday, August 10, 2023

SAN DIEGO, Aug. 10, 2023 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect themselves from severe allergic reactions that could lead to anaphylaxis, today reported business updates and financial results for the second quarter of 2023.

Key Points: 
  • Topline data from the company’s ongoing Phase 2 randomized, placebo-controlled study of neffy in urticaria patients are expected by the fourth quarter of 2023.
  • R&D Expenses: Research and development (R&D) expenses were $7.3 million for the quarter ended June 30, 2023.
  • G&A Expenses: General and administrative (G&A) expenses were $13.3 million for the quarter ended June 30, 2023.
  • Net Loss: Net loss was $17.4 million for the quarter ended June 30, 2023.

25th Anniversary V Foundation Wine Celebration Raises Record – Breaking $21 Million

Retrieved on: 
Monday, August 7, 2023

The V Foundation for Cancer Research , a top-rated cancer research charity, announced the 25th Anniversary V Foundation Wine Celebration , held August 3 - 6, 2023, raised a record-breaking $21 million in the Napa Valley, with 100% of proceeds supporting novel ideas and breakthroughs in cancer research.

Key Points: 
  • The V Foundation for Cancer Research , a top-rated cancer research charity, announced the 25th Anniversary V Foundation Wine Celebration , held August 3 - 6, 2023, raised a record-breaking $21 million in the Napa Valley, with 100% of proceeds supporting novel ideas and breakthroughs in cancer research.
  • View the full release here: https://www.businesswire.com/news/home/20230807080816/en/
    Event co-chair Amy Marks Dornbusch and the V Foundation Wine Celebration board of directors cheer the record $21 Million raised.
  • (Photo: Business Wire)
    Hosted by Mike “Coach K” Krzyzewski, former Head Coach of Duke University Men’s Basketball and V Foundation Board Member, the 25th Anniversary Wine Celebration entertained and educated over 600 guests in the heart of the Napa Valley.
  • For more information about the 25th Anniversary Wine Celebration Weekend, or to make a donation, please visit winecelebration.org.

GLOBAL SARCOMA THERAPY NOW LISTED ON PHARMACEUTICAL BENEFITS SCHEME

Retrieved on: 
Monday, July 31, 2023

SINGAPORE, July 31, 2023 /PRNewswire/ -- AUSTRALIAN cancer patients who have been diagnosed with rare soft tissue sarcomas will now have affordable access to a global therapy shown to improve survival, following its listing on the Pharmaceutical Benefits Scheme (PBS).

Key Points: 
  • SINGAPORE, July 31, 2023 /PRNewswire/ -- AUSTRALIAN cancer patients who have been diagnosed with rare soft tissue sarcomas will now have affordable access to a global therapy shown to improve survival, following its listing on the Pharmaceutical Benefits Scheme (PBS).
  • So, for patients to have access to a global therapy in their own country is wonderful news."
  • "For too long, sarcoma patients have been unable to access all therapies which may provide benefit," he said.
  • YONDELIS is marketed in Australia by independent pharmaceutical company Specialised Therapeutics, under an exclusive license arrangement with international partner PharmaMar.

Trevena, Inc. Appoints Mark Corrigan, M.D. to Board of Directors

Retrieved on: 
Thursday, July 20, 2023

has been appointed to the Company’s Board of Directors, effective July 18 2023.

Key Points: 
  • has been appointed to the Company’s Board of Directors, effective July 18 2023.
  • “We are pleased to welcome Mark to Trevena’s Board of Directors,” said Carrie Bourdow, Trevena’s President and CEO.
  • “Mark has over 30 years of experience in the life sciences industry and broad neuroscience expertise.
  • Dr. Corrigan serves as Chairman of the Board of Directors of Elios Therapeutics and as a member of the Board of Directors of Nabriva Therapeutics and Wave Life Sciences.

Edtech ReadWorks Adds Decodables, a Crucial Learning Tool for Early Readers

Retrieved on: 
Tuesday, July 18, 2023

BROOKLYN, N.Y., July 18, 2023 /PRNewswire/ -- ReadWorks, a nonprofit edtech leader offering free resources, tools, and content for reading comprehension, adds new nonfiction decodables to its online platform. It is vital to give early readers the opportunity to build background knowledge while practicing the letter-sound code that brings reading to life. Enter the new decodables on ReadWorks – a series of short, nonfiction texts designed to enhance curriculum and teacher instruction. Developed with expert writers and early reading thought leaders to complement the fiction decodables ReadWorks offers in partnership with Whole Phonics, these new decodables enable teachers to harness even more of the high-quality tools and sequences that ReadWorks offers.

Key Points: 
  • It is vital to give early readers the opportunity to build background knowledge while practicing the letter-sound code that brings reading to life.
  • Here are the powerful features and benefits of the new ReadWorks nonfiction decodables and how they can be used to revolutionize early literacy education.
  • The new ReadWorks decodables are all nonfiction, a rare and significant addition to strong early literacy instruction.
  • Teachers can find decodables within the Article-A-Day Scope & Sequence on ReadWorks now, and ReadWorks is offering a webinar titled Fostering Joy in Early Readers, How to Use New Decodables on ReadWorks on August 15th.